Rescue Studies: CRO Changeovers That Work

Too often, sponsors facing enrollment challenges in specific regions are forced into a false choice: accept the delay or close the country. But there’s a better path. Confidence Pharmaceutical Research helps sponsors preserve their global footprint by replacing underperforming CROs or site networks with focused, region-specific solutions—reviving enrollment without sacrificing time or geography. Switching to […]

From Clinical Trials to Unbroken: Sushmitha’s Journey of Leadership and Resilience

At Confidence Pharmaceutical Research, we know that the strength of our work comes from the people behind it. This month, we’re shining a spotlight on one of our Clinical Project Managers, Sushmitha Madhukar, whose career path in clinical research and recent journey as an author remind us how perseverance can shape both science and life. […]

Patient Enrollment and Retention in Rare Disease Studies

Clinical development in rare and orphan indications is often defined by urgency, unmet need, and an extraordinary level of complexity. While scientific innovation continues to drive therapeutic breakthroughs, many rare disease studies struggle to meet one fundamental milestone: patient enrollment and retention.   At Confidence Pharmaceutical Research, we’ve supported trials in more than a dozen […]

Rescue Rangers: How Confidence Takes Over and Rejuvenates Ailing Studies

Clinical trials involve many moving parts—protocol design, site performance, patient engagement, regulatory timelines, vendor coordination. While strong planning is essential, missed milestones often trace back to misaligned feasibility assessments, under-supported sites, or lack of adaptability to arising challenges once the trial is underway. Running trials effectively isn’t just about planning well—it’s about anticipating challenges and […]

Accelerated Approval: A Lifeline for Unmet Medical Needs

In a world where every second counts for patients with life-threatening conditions, the U.S. Food and Drug Administration’s (FDA) Accelerated Approval pathway offers a lifeline. It’s not just about speeding up approvals—it’s about saving lives. Introduced in 1992, this mechanism allows for therapies targeting serious diseases to reach patients faster, often using surrogate markers that […]